The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
Open accessAbstract
BACKGROUND: Studies in Europe have suggested that injectable diacetylmorphine, the active ingredient in heroin, can be an effective adjunctive treatment for chronic, relapsing opioid dependence. METHODS: In an open-label, phase 3, randomized, controlled trial in Canada, we compared injectable diacetylmorphine with oral methadone maintenance therapy in patients with opioid dependence that was refractory to treatment. Long-term users of injectable heroin who had not benefited from at least two previous attempts at treatment for addiction (including at least one methadone treatment) were randomly assigned to receive methadone (111 patients) or diacetylmorphine (115 patients). The primary outcomes, assessed at 12 months, were retention in addiction treatment or drug-free status and a reduction in illicit-drug use or other illegal activity according to the European Addiction Severity Index. RESULTS: The primary outcomes were determined in 95.2% of the participants. On the basis of an intention-to-treat analysis, the rate of retention in addiction treatment in the diacetylmorphine group was 87.8%, as compared with 54.1% in the methadone group (rate ratio for retention, 1.62; 95% confidence interval [CI], 1.35 to 1.95; P<0.001). The reduction in rates of illicit-drug use or other illegal activity was 67.0% in the diacetylmorphine group and 47.7% in the methadone group (rate ratio, 1.40; 95% CI, 1.11 to 1.77; P=0.004). The most common serious adverse events associated with diacetylmorphine injections were overdoses (in 10 patients) and seizures (in 6 patients). CONCLUSIONS: Injectable diacetylmorphine was more effective than oral methadone. Because of a risk of overdoses and seizures, diacetylmorphine maintenance therapy should be delivered in settings where prompt medical intervention is available. (ClinicalTrials.gov number, NCT00175357.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Self-report among injecting drug users: A review
Darke, S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00028-3 · Cited by 1,141
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Kokkevi, A., & Hartgers, C. (1995) · European Addiction Research · doi:10.1159/000259089 · Cited by 542
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
The Addiction Severity Index at 25: Origins, contributions, and transitions
McLellan, A. T., Cacciola, J. C., Alterman, A. I., Rikoon, S. H., & Carise, C. (2006) · The American Journal on Addictions · doi:10.1080/10550490500528316 · Cited by 450
Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review
Farrell, M., Ward, J., Mattick, R., Hall, W., Stimson, G. V., des Jarlais, D., Gossop, M., & Strang, J. (1994) · BMJ · doi:10.1136/bmj.309.6960.997 · Cited by 392
van den Brink, W., Hendriks, V. M., Blanken, P., Koeter, M. W. J., van Zwieten, B. J., & van Ree, J. M. (2003) · BMJ · doi:10.1136/bmj.327.7410.310 · Cited by 347
Heroin-assisted treatment for opioid dependence: Randomised controlled trial
Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.026112 · Cited by 264
Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A., & Uchtenhagen, A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06529-1 · Cited by 235
Substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub2 · Cited by 204
Controlled trial of prescribed heroin in the treatment of opioid addiction
March, J. C., Oviedo‐Joekes, E., Perea‐Milla, E., & Carrasco, F. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.04.007 · Cited by 158
Self-citationTermorshuizen, F., Krol, A., Prins, M., Geskus, R. B., van den Brink, W., & van Ameijden, E. J. C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.01.013 · Cited by 118
An overview of illegal opioid use and health services utilization in Canada
Popova, S., Rehm, J. T., & Fischer, B. (2006) · Public Health · doi:10.1016/j.puhe.2005.09.010 · Cited by 55
Safety of injectable opioid maintenance treatment for heroin dependence
Stoermer, R., Drewe, J., Farland, K. M. D.-M., Höck, C., Müller-Spahn, F., Ladewig, D., Stohler, R., & Mager, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00290-7 · Cited by 35
Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry
Goldstein, M. F., Deren, S., Kang, S.-Y., Jarlais, D. C. D., & Magura, S. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00199-5 · Cited by 32
Seizures and substance abuse: Treatment considerations
Brust, J. C. M. (2006) · Neurology · doi:10.1212/wnl.67.12_suppl_4.s45 · Cited by 28
New aspects in the treatment of heroin dependence with special reference to neurobiological aspects
Ladewig, D., Dürsteler‐MacFarland, K. M., Seifritz, E., Höck, C., & Stohler, R. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00644-2 · Cited by 7
Cited by
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Retention in medication-assisted treatment for opiate dependence: A systematic review
Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1100960 · Cited by 489
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.10.006 · Cited by 336
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Metadata
- Authors
- Oviedo-Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D., Anis, A., & Schechter, M. T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-08-20
- Volume
- 361
- Issue
- 8
- Pages
- 777-786
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2111198740
- Cited by
- 375
- References
- 19
- FWCI
- 26.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.